Haley A Losh

Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer

K. Thiel, Jianling Bi, Yuping Zhang, 2022, Cell death & disease.

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

K. Thiel, Jianling Bi, Yuping Zhang, 2021, Pharmaceuticals.

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

K. Thiel, Jianling Bi, Yuping Zhang, 2021, Pharmaceuticals.